Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Synonyms||Antibiotic Ad 32|AD-32|
Valstar (valrubicin) is an anthracycline that is metabolized into compounds that inhibit topoisomerase II, resulting in inhibition of DNA synthesis and potentially leading to decreased tumor growth (PMID: 19145271, PMID: 20554745). Valstar (valrubicin) is FDA-approved for treatment of BCG-refractory urinary bladder carcinoma in situ (FDA.gov).
|DrugClasses||Chemotherapy - Anthracycline 13 TOPO2 inhibitor 5|
|CAS Registry Number||56124-62-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Gemcitabine + Interferon gamma + Mitomycin C + Valrubicin||Gemcitabine Interferon gamma Mitomycin C Valrubicin||0||0|